JP2014518214A5 - - Google Patents

Download PDF

Info

Publication number
JP2014518214A5
JP2014518214A5 JP2014516020A JP2014516020A JP2014518214A5 JP 2014518214 A5 JP2014518214 A5 JP 2014518214A5 JP 2014516020 A JP2014516020 A JP 2014516020A JP 2014516020 A JP2014516020 A JP 2014516020A JP 2014518214 A5 JP2014518214 A5 JP 2014518214A5
Authority
JP
Japan
Prior art keywords
methyl
azaspiro
oxa
oxo
carbonitrile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014516020A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014518214A (ja
JP5969017B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/042622 external-priority patent/WO2013012500A1/en
Publication of JP2014518214A publication Critical patent/JP2014518214A/ja
Publication of JP2014518214A5 publication Critical patent/JP2014518214A5/ja
Application granted granted Critical
Publication of JP5969017B2 publication Critical patent/JP5969017B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014516020A 2011-06-17 2012-06-15 Trpv4拮抗薬 Active JP5969017B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161498110P 2011-06-17 2011-06-17
US61/498,110 2011-06-17
PCT/US2012/042622 WO2013012500A1 (en) 2011-06-17 2012-06-15 Trpv4 antagonists

Publications (3)

Publication Number Publication Date
JP2014518214A JP2014518214A (ja) 2014-07-28
JP2014518214A5 true JP2014518214A5 (enExample) 2015-07-16
JP5969017B2 JP5969017B2 (ja) 2016-08-10

Family

ID=47558389

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014516020A Active JP5969017B2 (ja) 2011-06-17 2012-06-15 Trpv4拮抗薬

Country Status (38)

Country Link
US (1) US9187464B2 (enExample)
EP (2) EP3121177B1 (enExample)
JP (1) JP5969017B2 (enExample)
KR (1) KR101870003B1 (enExample)
CN (1) CN103732583B (enExample)
AR (1) AR086958A1 (enExample)
AU (1) AU2012284540B2 (enExample)
BR (1) BR112013032391B1 (enExample)
CA (1) CA2839743C (enExample)
CL (1) CL2013003602A1 (enExample)
CO (1) CO6821953A2 (enExample)
CR (1) CR20130671A (enExample)
CY (1) CY1117792T1 (enExample)
DK (1) DK2721016T3 (enExample)
DO (1) DOP2013000307A (enExample)
EA (1) EA023616B1 (enExample)
ES (2) ES2688733T3 (enExample)
HR (1) HRP20160539T1 (enExample)
HU (1) HUE029594T2 (enExample)
IL (1) IL229872A (enExample)
JO (1) JO3154B1 (enExample)
MA (1) MA35184B1 (enExample)
ME (1) ME02416B (enExample)
MX (1) MX337440B (enExample)
MY (1) MY173521A (enExample)
PE (1) PE20141943A1 (enExample)
PH (1) PH12013502463A1 (enExample)
PL (1) PL2721016T3 (enExample)
PT (1) PT2721016E (enExample)
RS (1) RS54858B1 (enExample)
SG (1) SG195106A1 (enExample)
SI (1) SI2721016T1 (enExample)
SM (1) SMT201600150B (enExample)
TW (1) TWI538912B (enExample)
UA (1) UA113963C2 (enExample)
UY (1) UY34138A (enExample)
WO (1) WO2013012500A1 (enExample)
ZA (1) ZA201308816B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9487507B2 (en) 2011-06-17 2016-11-08 Glaxosmithkline Intellectual Property (No. 2) Limited TRPV4 antagonists
EP2720697B1 (en) 2011-06-17 2016-07-20 Glaxosmithkline Intellectual Property (No. 2) Limited Trpv4 antagonists
JPWO2013146754A1 (ja) 2012-03-27 2015-12-14 塩野義製薬株式会社 Trpv4阻害活性を有する芳香族複素5員環誘導体
WO2015046193A1 (ja) 2013-09-25 2015-04-02 塩野義製薬株式会社 Trpv4阻害活性を有する芳香族複素環式アミン誘導体
JP6970691B2 (ja) * 2016-05-19 2021-11-24 グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited Trpv4拮抗薬
US10968209B2 (en) 2016-05-19 2021-04-06 Glaxosmithkline Intellectual Property (No.2) Limited TRPV4 antagonist
EP3519413A1 (en) 2016-10-03 2019-08-07 Janssen Pharmaceutica NV Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors
WO2018185701A1 (en) 2017-04-06 2018-10-11 Glaxosmithkline Intellectual Property (No.2) Limited Trpv4 antagonists as antitussive agents
MX2020004400A (es) * 2017-11-01 2020-08-06 Bristol Myers Squibb Co Compuestos espirociclicos como moduladores del receptor farnesoide x.
WO2021170811A1 (en) 2020-02-27 2021-09-02 Glaxosmithkline Intellectual Property (No.2) Limited Method of treating eye disease using trpv4 antagonists
WO2021221169A1 (en) 2020-04-30 2021-11-04 Raqualia Pharma Inc. Pyrimidin-4(3h)-one derivatives as trpv4 antagonists
CN111704613B (zh) * 2020-06-23 2021-07-06 中国人民解放军军事科学院军事医学研究院 咪唑类衍生物及其作为trpv4抑制剂的用途
KR20230041680A (ko) * 2020-07-16 2023-03-24 라퀄리아 파마 인코포레이티드 안구 질환 치료제로서의 trpv4 억제제
EP4551572A1 (en) 2022-07-08 2025-05-14 Actio Biosciences, Inc. Therapeutic compounds and methods
WO2024217452A1 (zh) * 2023-04-18 2024-10-24 河北乌图药业有限公司 化合物及其在慢性乙型肝炎、肝纤维化、肝癌的治疗中的应用
WO2024217446A1 (zh) * 2023-04-18 2024-10-24 河北乌图药业有限公司 化合物及其在慢性乙型肝炎、肝纤维化、肝癌的治疗中的应用
WO2024217428A1 (zh) * 2023-04-18 2024-10-24 河北乌图药业有限公司 化合物及其在慢性乙型肝炎、肝纤维化、肝癌的治疗中的应用
WO2024217439A1 (zh) * 2023-04-18 2024-10-24 河北乌图药业有限公司 化合物及其在慢性乙型肝炎、肝纤维化、肝癌的治疗中的应用
WO2024217429A1 (zh) * 2023-04-18 2024-10-24 河北乌图药业有限公司 化合物及其在慢性乙型肝炎、肝纤维化、肝癌的治疗中的应用
WO2025014818A1 (en) * 2023-07-07 2025-01-16 Actio Biosciences, Inc. Solid forms of gsk2798745, a trpv4 antagonist

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4549534B2 (ja) * 1998-05-26 2010-09-22 中外製薬株式会社 複素環を有するインドール誘導体及びモノ又はジアザインドール誘導体
JP2007534624A (ja) * 2003-07-16 2007-11-29 ニューロジェン・コーポレーション ビアリールピペラジニル−ピリジン類縁体
BRPI0618863A2 (pt) * 2005-11-23 2016-09-13 Painceptor Pharma Corp métodos de modular a atividade de um canal iônico dependente e de tratar dor, uma transtorno associado aos sistemas genitourinário ou gastrointestinal em um indivíduo e, composto
WO2007067756A2 (en) 2005-12-08 2007-06-14 Amphora Discovery Corporation Certain chemical entities, compositions, and methods for modulating trpv1
ES2436225T3 (es) * 2005-12-22 2013-12-27 Hydra Biosciences, Inc. Inhibidores TRPA1 para tratamiento del dolor
TW200819457A (en) * 2006-08-30 2008-05-01 Actelion Pharmaceuticals Ltd Spiro antibiotic derivatives
TW200900060A (en) * 2007-02-01 2009-01-01 Glaxo Group Ltd Chemical compounds
GB0707934D0 (en) * 2007-04-24 2007-05-30 Glaxo Group Ltd Chemical compounds
CN101801953A (zh) * 2007-08-09 2010-08-11 雅培制药有限公司 作为trpv1拮抗剂的四氢吡啶甲酰胺衍生物
TW200944520A (en) 2008-01-29 2009-11-01 Glaxo Group Ltd Spiro compounds as NPY Y5 receptor antagonists
JP5607046B2 (ja) * 2008-07-25 2014-10-15 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー Trpv4拮抗薬
JP2012006837A (ja) * 2008-09-30 2012-01-12 Mochida Pharmaceut Co Ltd 2−インドールアクリルアミド類縁体
WO2012024183A1 (en) * 2010-08-18 2012-02-23 Merck Sharp & Dohme Corp. Spiroxazolidinone compounds
EP2720697B1 (en) 2011-06-17 2016-07-20 Glaxosmithkline Intellectual Property (No. 2) Limited Trpv4 antagonists
US9487507B2 (en) * 2011-06-17 2016-11-08 Glaxosmithkline Intellectual Property (No. 2) Limited TRPV4 antagonists

Similar Documents

Publication Publication Date Title
JP2014518214A5 (enExample)
HRP20160539T1 (hr) Antagonisti trpv4
CN105339370B (zh) 用于治疗炎症性疾病的化合物和及其药物组合物
JP2014525444A5 (enExample)
KR101439823B1 (ko) 골수증식성 질환 및 기타 증식성 질환의 치료에 유용한 키나제 억제제
ES2642586T3 (es) Compuestos heterocíclicos condensados como moduladores de canales iónicos
US9434743B2 (en) Indazole derivatives
JP2021501220A5 (enExample)
JP2018118992A5 (enExample)
JP2014531465A5 (enExample)
US20230092892A1 (en) Amino quinazoline derivatives as p2x3 inhibitors
JP2013508404A5 (enExample)
JP2014528446A5 (enExample)
JP2019519484A5 (enExample)
HRP20180546T1 (hr) Supstituirani benzilindazoli za uporabu kao inhibitori bub1 kinaze za liječenje hiperproliferativnih bolesti
RU2016102647A (ru) Ингибиторы бромодомена
JP2010502615A5 (enExample)
JP2018534326A5 (enExample)
RU2017105296A (ru) Новые соединения
JP2017500362A5 (enExample)
JP2015517580A5 (enExample)
JP2020527560A5 (enExample)
JP2010524970A5 (enExample)
JP2016500073A5 (enExample)
JP2017500364A5 (enExample)